These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30381401)

  • 1. Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo.
    Yang M; Kholmukhamedov A; Schulte ML; Cooley BC; Scoggins NO; Wood JP; Cameron SJ; Morrell CN; Jobe SM; Silverstein RL
    Blood Adv; 2018 Nov; 2(21):2848-2861. PubMed ID: 30381401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions.
    Yang M; Cooley BC; Li W; Chen Y; Vasquez-Vivar J; Scoggins NO; Cameron SJ; Morrell CN; Silverstein RL
    Blood; 2017 May; 129(21):2917-2927. PubMed ID: 28336528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function.
    Yang M; Silverstein RL
    Curr Opin Hematol; 2019 Sep; 26(5):357-365. PubMed ID: 31261174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized LDL activates blood platelets through CD36/NOX2-mediated inhibition of the cGMP/protein kinase G signaling cascade.
    Magwenzi S; Woodward C; Wraith KS; Aburima A; Raslan Z; Jones H; McNeil C; Wheatcroft S; Yuldasheva N; Febbriao M; Kearney M; Naseem KM
    Blood; 2015 Apr; 125(17):2693-703. PubMed ID: 25710879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein.
    Chen K; Febbraio M; Li W; Silverstein RL
    Circ Res; 2008 Jun; 102(12):1512-9. PubMed ID: 18497330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia.
    Yang M; Li W; Harberg C; Chen W; Yue H; Ferreira RB; Wynia-Smith SL; Carroll KS; Zielonka J; Flaumenhaft R; Silverstein RL; Smith BC
    Blood Adv; 2020 Sep; 4(18):4494-4507. PubMed ID: 32946569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
    Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
    Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase-signaling pathways.
    Wraith KS; Magwenzi S; Aburima A; Wen Y; Leake D; Naseem KM
    Blood; 2013 Jul; 122(4):580-9. PubMed ID: 23699602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual mechanism of integrin αIIbβ3 closure in procoagulant platelets.
    Mattheij NJ; Gilio K; van Kruchten R; Jobe SM; Wieschhaus AJ; Chishti AH; Collins P; Heemskerk JW; Cosemans JM
    J Biol Chem; 2013 May; 288(19):13325-36. PubMed ID: 23519467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36.
    Qi Z; Hu L; Zhang J; Yang W; Liu X; Jia D; Yao Z; Chang L; Pan G; Zhong H; Luo X; Yao K; Sun A; Qian J; Ding Z; Ge J
    Circulation; 2021 Jan; 143(1):45-61. PubMed ID: 32988222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state.
    Chen K; Li W; Major J; Rahaman SO; Febbraio M; Silverstein RL
    Blood; 2011 May; 117(21):5744-50. PubMed ID: 21427288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fibrin causes an acquired platelet glycoprotein VI signaling defect: implications for coagulopathy.
    Lee MY; Verni CC; Herbig BA; Diamond SL
    J Thromb Haemost; 2017 Dec; 15(12):2396-2407. PubMed ID: 28981200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A.
    Korporaal SJ; Van Eck M; Adelmeijer J; Ijsseldijk M; Out R; Lisman T; Lenting PJ; Van Berkel TJ; Akkerman JW
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2476-83. PubMed ID: 17761940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets.
    Choo HJ; Kholmukhamedov A; Zhou C; Jobe S
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1503-1512. PubMed ID: 28663253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD36-fibrin interaction propagates FXI-dependent thrombin generation of human platelets.
    Döhrmann M; Makhoul S; Gross K; Krause M; Pillitteri D; von Auer C; Walter U; Lutz J; Volf I; Kehrel BE; Jurk K
    FASEB J; 2020 Jul; 34(7):9337-9357. PubMed ID: 32463151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet adhesion enhances the glycoprotein VI-dependent procoagulant response: Involvement of p38 MAP kinase and calpain.
    Siljander P; Farndale RW; Feijge MA; Comfurius P; Kos S; Bevers EM; Heemskerk JW
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):618-27. PubMed ID: 11304481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling role of CD36 in platelet activation and thrombus formation on immobilized thrombospondin or oxidized low-density lipoprotein.
    Nergiz-Unal R; Lamers MM; Van Kruchten R; Luiken JJ; Cosemans JM; Glatz JF; Kuijpers MJ; Heemskerk JW
    J Thromb Haemost; 2011 Sep; 9(9):1835-46. PubMed ID: 21696539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoproteomic analysis of platelets activated by pro-thrombotic oxidized phospholipids and thrombin.
    Zimman A; Titz B; Komisopoulou E; Biswas S; Graeber TG; Podrez EA
    PLoS One; 2014; 9(1):e84488. PubMed ID: 24400094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib Inhibits Procoagulant and Clot Retracting Activities of Human Platelets.
    Beke Debreceni I; Mezei G; Batár P; Illés Á; Kappelmayer J
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low-density lipoprotein-dependent platelet-derived microvesicles trigger procoagulant effects and amplify oxidative stress.
    Wang H; Wang ZH; Kong J; Yang MY; Jiang GH; Wang XP; Zhong M; Zhang Y; Deng JT; Zhang W
    Mol Med; 2012 Mar; 18(1):159-66. PubMed ID: 22064971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.